Skip to main content
Blood logoLink to Blood
. 2017 Jul 13;130(2):232. doi: 10.1182/blood-2017-05-787366

Fischer K, Al-Sawaf O, Fink A-M, et al. Venetoclax and obinutuzumab in chronic lymphocytic leukemia. Blood. 2017;129(19):2702-2705.

PMCID: PMC5510794  PMID: 28705863

On page 2702 in the 11 May 2017 issue, there is an error in the dosage of obinutuzumab in line 7 of the second paragraph. The text “100 mg on day 1900 mg on day 2” should read “100 mg on day 1 and 900 mg on day 2.” The error has been corrected in the online version, which now differs from the print version.


Articles from Blood are provided here courtesy of The American Society of Hematology

RESOURCES